Does your study design and assumptions ensure the highest level of compliance?

Are your CMC and Clinical plans aligned to ensure efficient use of drug product and minimize regulatory constraints?

Do you fully understand the impact of your selected countries?

Have you identified a robust supply chain for your comparators and concomitant medicines?

Do you have a long-term forecast generated from cross-functional assumptions?

Will your vendor network ensure quality, compliance and on time delivery of product?